Clinical Trials Browser

Phase 3 × INDUSTRY × icaritin × Clear all

NCT05594927 2024-08-07

BESTPOP

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03236649 2023-02-08

The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular